December 19 #LCSM Chat: “Lung Cancer Screening – The Good, The Bad and the Indolent”

The next #LCSM Chat will occur on December 19 at 5 PM Pacific Time (8 PM ET), and will be moderated by Janet Freeman-Daily.  The theme will be “Lung Cancer Screening – The Good, The Bad and the Indolent.” Discussion topics for #LCSM Chat: T1: For patients who don’t fit “older heavy smoker” profile, should doctor order low-dose CT screening if patient requests it? #LCSM T2: Some lung nodules are not cancer. When are you comfortable just watching a lung nodule instead of treating it? #LCSM T3: A new blood test detects… Read More

Tweets for #LCAM2013 Week 3 — Hope for Lung Cancer Patients

  For Lung Cancer Awareness Month (#LCAM2013), the #LCSM team compiled a list of tweet-sized lung cancer facts – one tweet for each day in November. We ask all #LCSM participants and lung cancer advocates to tweet the fact of the day at noon Eastern time (9 AM Pacific) to help with trending.  You can come here to copy the tweet of the day, or  if you prefer, you can retweet the fact after @LCSMChat tweets each day at 11:55 AM Eastern Time. Our tweets for the third week of Lung Cancer Awareness Month… Read More

How Much Evidence Do We Really Need to Change Treatment Recommendations? – October 10

By Dr. H. Jack West One ongoing controversy in the world of managing cancer, especially one in which cures are elusive, is how high the bar should be to guide treatment recommendations. The “gold standard” to change treatment is a significant improvement in the primary endpoint, ideally overall survival, in a prospective, randomized phase III trial with several hundred or even several thousand people. In some settings, treatment recommendations may not even change until a few randomized phase III trials show the same significant improvement with a new treatment approach. But the reality is that sometimes we want… Read More